China
Africa
Explore chapters and articles related to this topic
Machine Learning Approach to Overcome the Challenges in Theranostics
Published in Shampa Sen, Leonid Datta, Sayak Mitra, Machine Learning and IoT, 2018
Bishwambhar Mishra, Sayak Mitra, Karthikeya Srinivasa Varma Gottimukkala, Shampa Sen
CXCR4 is a member of the chemokine receptor subfamily of seven transmembrane domain, G-protein coupled receptors, whose sole known natural ligand is CXCL12/SDF-1. CXCR4 is an unusual chemokine receptor by virtue of having expanded roles beyond leukocyte recruitment, including fundamental processes such as the development of the hematopoietic, cardiovascular, and nervous systems during embryogenesis. The receptor was first discovered as one of the coreceptors for HIV, and thereafter was also found to be expressed by multiple cancers including breast, prostate, lung, colon, and multiple myeloma.
Static electric field exposure decreases white blood cell count in peripheral blood through activating hypothalamic–pituitary–adrenal axis
Published in International Journal of Environmental Health Research, 2022
Jiahong Wu, Li Dong, Junli Xiang, Guoqing Di
Following the activation of HPA axis, the increased CORT in peripheral blood diffuses into cells and binds to the glucocorticoid receptor (GR), resulting in the rise of concentration of intracellular CORT-GR complex (Bekhbat et al. 2017). The CORT-GR complex then translocates from cytoplasm to nucleus and binds to glucocorticoid response elements in the target gene’s promoter, which can promote the expression of target gene such as C-X-C motif chemokine receptor 4 (CXCR4) (Shimba and Ikuta 2020). The interaction between CXCR4 and its specific ligand CXCL12 plays a pivotal role in guiding cells into specific locations in vivo (Cesare et al. 2007). Previous studies demonstrated that the CORT-GR complex could significantly upregulate the expression of CXCR4 gene in lymphocytes (Besedovsky et al. 2014; Cain et al. 2020), which could induce lymphocytes to migrate from peripheral blood to the tissues with high CXCL12 levels (e.g. bone marrow, spleen and lung) (Engler et al. 2004). On the basis of the analysis above, it is concluded that one critical reason for the decrease of total WBC count and lymphocyte count in this study is that HPA axis is activated after the SEF exposure of 7d and 14d. CORT, the end-product of HPA axis, induces lymphocytes to migrate out of peripheral blood by upregulating CXCR4 gene expression. To more clearly present the process in which the SEF exposure of 7d and 14d induces the migration of lymphocytes, the discussion above is visually summarized in Figure 4(a).
Dendrimer as a promising nanocarrier for the delivery of doxorubicin as an anticancer therapeutics
Published in Journal of Biomaterials Science, Polymer Edition, 2021
Vanshikha Singh, Prashant Kesharwani
Breast cancer is undoubtedly one of the very commonly diagnosed cancer in women, in which cells in different region of breast starts uncontrolled differentiation. This invasive cancer is characterized by additional property of metastasis in which the malignant cancer cells advances toward other regions of body including liver, bones, brain, lungs, lymph nodes, etc. C-X-C chemokine receptor type 4 (CXCR4) along with its ligand CXCL12 plays vital role in the process of metastasis of different types of cancer. The high level of CXCL12 in these organs serves as chemoattractant to drive CXCR4 positive primary tumor cell toward secondary metastatic sites. CXCR4 are highly expressed only in cancerous tissue and the normal cells usually stay devoid of them, this characteristic of CXCR4 can be used to deliver anticancer drug targeted at the tumor site [107].
Peptide-enabled receptor-binding-quantum dots for enhanced detection and migration inhibition of cancer cells
Published in Journal of Biomaterials Science, Polymer Edition, 2020
Ruijuan Zu, Xiaocui Fang, Yuchen Lin, Shilin Xu, Jie Meng, Haiyan Xu, Yanlian Yang, Chen Wang
Capabilities of sensitive detection and effective inhibition of cancer cell migration are keen for cancer treatment. Thematic investigations in this area have been pursued with extensive efforts [1,2]. As one of the representative progresses in cancer development and metastasis, chemokine receptor CXCR4, one of seven-transmembrane G-coupled receptors, is expressed in variable amounts on primary leukemic cells and solid tumor cells. It has been confirmed that CXCR4 is functionally active and mediates trafficking of cancer cells induced by chemokine stromal cell-derived factor-1 (SDF-1, also termed as CXCL12) [3].